One year on from the UK s first Covid cases - how the battle to save lives unfolded from a hotel in York
It has been one year since a York student was taken ill before becoming the first person in the UK to test positive for coronavirus. Fionnula Hainey reports on how the battle to save lives has unfolded since.
The cheap drug that saves lives by revolutionising Covid treatment
The treatment was immediately rolled out across NHS hospitals
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Dexamethasone has become the “backbone” of the hospital treatment of patients with Covid-19, a senior medic said.
The cheap steroid was found to reduce death rates by up to a third among some hospital patients.
The entrance to one of five Covid-19 wards at Whiston Hospital (PA)
Sign up for our daily newsletter featuring the top stories from The Press and Journal.
Thank you for signing up to The Press and Journal newsletter.
Something went wrong - please try again later. Sign Up
Dexamethasone has become the “backbone” of the hospital treatment of patients with Covid-19, a senior medic said.
The cheap steroid was found to reduce death rates by up to a third among some hospital patients.
The University of Oxford-led clinical trial was hailed as “the world’s first coronavirus treatment proven to reduce the risk of death”, after the team reported its trial results in June last year.
Dexamethasone has become the “backbone” of the hospital treatment of patients with Covid-19, a senior medic said.
The cheap steroid was found to reduce death rates by up to a third among some hospital patients.
The University of Oxford-led clinical trial was hailed as “the world’s first coronavirus treatment proven to reduce the risk of death”, after the team reported its trial results in June last year.
The treatment was immediately rolled out across NHS hospitals.
And this treatment, along with others, could be behind the significant reduction in death rates among those admitted to intensive care units since the start of the pandemic.